Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA4Ag vaccine in adults undergoing elective posterior instrumented lumbar spinal fusion
2014-002644-40Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Staphylococcus aureus infection comparing SA4Ag vaccine with Placebo (2 arms). Started Mar 2015; status: terminated.
02
Drugs
Staphylococcus aureus 4-antigen vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on 2014-002644-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002644-40.